A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Christina L. Roland, Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin, Manoj Chelvanambi, Edwin R. Parra, Khalida Wani, B. Ashleigh Guadagnolo, Andrew J. Bishop, Elizabeth M. Burton, Kelly K. Hunt, Keila E. Torres, Barry W. Feig, Christopher P. Scally, Valerae O. Lewis, Justin E. Bird, Ravin Ratan, Dejka M. Araujo, M. Alexandra Zarzour, Shreyaskumar Patel, Robert S. Benjamin, Anthony P. Conley, J. Andrew Livingston, Vinod Ravi, Hussein A. Tawbi, Patrick P. Lin, Bryan S. Moon, Robert L. Satcher, Bilal Mujtaba, Russell G. Witt, Raymond Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M. Mohammad, Randy Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis R. Ingram, Rohini R. Morey, Shadarra Crosby, Grace Mathew, Sheila L. B. Duncan, Cibelle Lima, Jean‐Yves Blay, Wolf H. Fridman, Kenna M. Shaw, Ignacio Wistuba, P. Andrew Futreal, Nadim J. Ajami, Jennifer A. Wargo, Neeta Somaiah